AZ-DF 265 is a hypoglycaemic drug which stimulates insulin release. AZ-DF-265 inhibits ATP-sensitive potassium channels and displaces [3H]-glibenclamide from the sulphonylurea receptor. References: Ronner P, Hang TL, Kraebber MJ, Higgins TJ. Effect of the hypoglycaemic drug (-)-AZ-DF-265 on ATP-sensitive potassium channels in rat pancreatic beta-cells. Br J Pharmacol. 1992 Jun;106(2):250-5. PubMed PMID: 1393260; PubMed Central PMCID: PMC1907504.

纯度：≥98%

CAS：83901-40-0